During the past decade, Victoria Cardiac Arrhythmia Trials Inc. conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 8 clinical trials were completed, i.e. on average, 57.1% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 5 clinical trials were completed. i.e. 500% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Victoria Cardiac Arrhythmia Trials Inc." #1 sponsor was "Ottawa Heart Institute Research Corporation" with 6 trials, followed by "Medtronic Cardiac Rhythm and Heart Failure" with 4 trials sponsored, "Population Health Research Institute" with 3 trials sponsored, "Boehringer Ingelheim" with 2 trials sponsored and "Milestone Pharmaceuticals Inc." with 2 trials sponsored. Other sponsors include 5 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Victoria Cardiac Arrhythmia Trials Inc." #1 collaborator was "Canadian Institutes of Health Research (CIHR)" with 5 trials as a collaborator, "Medtronic" with 5 trials as a collaborator, "Bayer" with 2 trials as a collaborator, "Bristol-Myers Squibb" with 2 trials as a collaborator and "Medpace, Inc." with 2 trials as a collaborator. Other collaborators include 8 different institutions and companies that were collaborators in the rest 18 trials.

According to Clinical.Site data, the most researched conditions in "Victoria Cardiac Arrhythmia Trials Inc." are "Atrial Fibrillation" (15 trials), "Stroke" (3 trials), "Heart Disease" (2 trials), "Heart Failure" (2 trials) and "Paroxysmal Supraventricular Tachycardia" (2 trials). Many other conditions were trialed in "Victoria Cardiac Arrhythmia Trials Inc." in a lesser frequency.

Most popular intervention types in "Victoria Cardiac Arrhythmia Trials Inc." are "Device" (14 trials), "Drug" (10 trials), "Procedure" (3 trials), "Diagnostic Test" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Apixaban" (2 trials), "Rivaroxaban" (2 trials), "Acetylsalicylic acid" (1 trials), "Aegis Sierra Ligation System" (1 trials) and "Anti-Arrhythmic Drug Therapy" (1 trials). Other intervention names were less common.

The vast majority of trials in "Victoria Cardiac Arrhythmia Trials Inc." are 27 trials for "All" genders.

Currently, there are NaN active trials in "Victoria Cardiac Arrhythmia Trials Inc.". 1 are not yet recruiting, 2 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 15 completed trials in Victoria Cardiac Arrhythmia Trials Inc., undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Victoria Cardiac Arrhythmia Trials Inc., 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 13 trials that are defined as “Not Applicable".